POLY MEDICURE Fact Sheet, POLY MEDICURE Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

POLY MEDICURE Fact Sheet    (POME)


FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit


Here is the latest financial fact sheet of POLY MEDICURE. For more details, see the POLY MEDICURE quarterly results and POLY MEDICURE share price and chart.

POLY MEDICURE Price History

Price Rs 979.5
Mkt Cap Rs m 93,910
Vol '000 12.0
P/E X 64.2
P/CF X 52.1
EPS (TTM) Rs 15.2
% ch % 2.3
No. of shares m 95.88
% ch week % 8.2
% ch 1-mth % 8.6
% ch 12-mth % 102.0
52 week H/L Rs 1,163.0/449.2
(As on Nov 26, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

POLY MEDICURE Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
POLY MEDICURE EQUITY SHARE DATA
High Rs633320298349913 
Low Rs216190176167207 
Sales per share (Unadj.) Rs50.858.869.277.982.0 
Earnings per share (Unadj.) Rs6.27.97.310.613.8 
Diluted earnings per shareRs5.77.26.79.813.8 
Cash flow per share (Unadj.) Rs8.911.211.515.218.8 
Dividends per share (Unadj.) Rs2.502.002.002.002.50 
Adj. dividends per shareRs2.301.841.841.842.50 
Avg Dividend yield %0.60.80.80.80.4 
Book value per share (Unadj.) Rs30.838.343.249.3100.6 
Adj. book value per shareRs28.335.239.745.3100.6 
Shares outstanding (eoy) m88.2388.2388.2488.2595.88 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x8.44.33.43.36.8 
Avg P/E ratio x68.732.432.724.340.5 
P/CF ratio (eoy) x47.922.820.717.029.8 
Price / Book Value ratio x13.86.75.55.25.6 
Dividend payout %40.425.427.618.818.1 
Avg Mkt Cap Rs m37,45222,49820,92822,76353,703 
No. of employees `000NANANANANA 
Total wages/salary Rs m8739911,1661,3881,418 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
POLY MEDICURE INCOME DATA
Net Sales Rs m4,4825,1926,1086,8727,865 
Other income Rs m135144185185184 
Total revenues Rs m4,6175,3356,2937,0578,049 
Gross profit Rs m9351,2201,3121,6612,165 
Depreciation Rs m237292373405475 
Interest Rs m87116137205106 
Profit before tax Rs m7469559871,2361,767 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m201262347298442 
Profit after tax Rs m5456946409371,326 
Gross profit margin %20.923.521.524.227.5 
Effective tax rate %26.927.435.124.225.0 
Net profit margin %12.213.410.513.616.9 
POLY MEDICURE BALANCE SHEET DATA
Current assets Rs m2,0492,5523,2933,5007,495 
Current liabilities Rs m1,1391,2261,8122,2552,151 
Net working cap to sales %20.325.524.218.167.9 
Current ratio x1.82.11.81.63.5 
Inventory Days Days21281843195 
Debtors Days Days787977675726 
Net fixed assets Rs m2,5203,0963,5234,4955,179 
Share capital Rs m441441441441479 
"Free" reserves Rs m2,2742,9383,3703,9069,168 
Net worth Rs m2,7153,3793,8114,3479,648 
Long term debt Rs m4767919141,144633 
Total assets Rs m4,5695,6486,8167,99512,674 
Interest coverage x9.69.28.27.017.6 
Debt to equity ratio x0.20.20.20.30.1 
Sales to assets ratio x1.00.90.90.90.6 
Return on assets %13.814.311.414.311.3 
Return on equity %20.120.516.821.613.7 
Return on capital %26.125.723.826.218.2 
Exports to sales %62.566.463.361.161.3 
Imports to sales %25.028.025.428.026.9 
Exports (fob) Rs m2,8013,4483,8674,2014,818 
Imports (cif) Rs m1,1181,4561,5541,9252,116 
Fx inflow Rs m2,8333,4483,8674,2014,818 
Fx outflow Rs m1,4941,4561,5541,9252,116 
Net fx Rs m1,3391,9922,3132,2752,702 
POLY MEDICURE CASH FLOW
From Operations Rs m 561 750 1,065 1,283 1,187 
From Investments Rs m -557 -880 -1,007 -1,073 -4,356 
From Financial Activity Rs m -3 157 -51 -205 3,169 
Net Cashflow Rs m 1 26 6 5 1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 44.8%
Institution 16.6%
Non-Institution 38.7%
Total 100.0%
Free Float 55.2%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 232b 3rd Floor, Okhla Industrial Estate, Phase I I I, New Delhi - 110020
E-MAIL investorcare@polymedicure.com WEB www.polymedicure.com
TEL 011 - 26321838 81 89 93 FAX 011 – 26321839 94
SECTOR MEDICAL EQUIPMENT/SUPPLIES/ACCESSORIES GROUP Private sector
TR AGENT MAS Services Ltd, T-34 2nd Floor, Okhla Industrial Area, Phase - II
AUDITOR Doogar & Assoc.
CHM: Devendra Raj Mehta COMP SEC: Sonia Singh YEAR OF INC: 1995 BSE CODE: 531768 FV (Rs): 5 DIV YIELD (%): 0.3

Read: POLY MEDICURE 2020-21 Annual Report Analysis

More Medical Equipment/supplies/accessories Company Fact Sheets:   TIJARIA POLYPIPES  SINDHU TRADE LINKS  OCEANAA BIOTEK  WE WIN  SHRIRAM PISTONS & RINGS  

Compare POLY MEDICURE With:   TIJARIA POLYPIPES  SINDHU TRADE LINKS  OCEANAA BIOTEK  WE WIN  SHRIRAM PISTONS & RINGS  




Today's Market

5 Reasons Why Sensex Crashed, Tarsons Products' Lukewarm Debut, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended deep in the red on Friday. Benchmark indices slipped nearly 3% on the back of a global sell-off following the emergence of new variant of Coivd-19.

Views on news

POLY MEDICURE 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of POLY MEDICURE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of POLY MEDICURE. Also includes updates on the valuation of POLY MEDICURE.

POLY MEDICURE Announces Quarterly Results (1QFY22); Net Profit Up 42.0% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, POLY MEDICURE has posted a net profit of Rs 369 m (up 42.0% YoY). Sales on the other hand came in at Rs 2 bn (up 24.4% YoY). Read on for a complete analysis of POLY MEDICURE's quarterly results.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

From Paytm to Reliance Power: Big IPOs with the Worst Debut Day Performance (Views On News)

Nov 22, 2021

Paytm's flop show should not come as a surprise. This is not the first time a high-profile IPO has eroded investors' wealth on listing day.

Top 5 Stocks in which FIIs Sequentially Raised their Stakes (Views On News)

Oct 26, 2021

FIIs have largely stayed on the sidelines this month, booking profits at every opportunity they get, amid tapering concerns.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK POLY MEDICURE

  • Track your investment in POLY MEDICURE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON POLY MEDICURE

POLY MEDICURE - CENTENIAL SURG. COMPARISON

COMPARE POLY MEDICURE WITH

MARKET STATS